Spectrum Pharmaceuticals, Inc. SPPI
Set alert
1.03 +1.03 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 210.38M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 7.34
- Beta
- 2.14
- Short ratio
- 2.69
- Inst. own
- 22.70%
- Dividend
- 0.00
- Ex-div date
- Dec 17, 2012
- Earnings
- Aug 10, 2023
- 50-d avg
- 1.08
- 200-d avg
- 0.71255
- 1y target
- 1.26
Analyst view
Consensus: hold
Hold
Price target (mean) 1.26 +22.9% upside
Now 1.03
- Target (low)
- 1.14
- Target (mean)
- 1.26
- Target (high)
- 1.50
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 5
- 2 months ago 5
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.07 – -0.01 | -0.17 | +82.4% | 16.52M | 0.0% | 3 |
| Next quarter | -0.01 | -0.03 – 0.01 | -0.12 | +91.7% | 19.39M | 0.0% | 3 |
| Current year | -0.05 | -0.09 – 0.01 | -0.41 | +87.8% | 73.38M | +625.5% | 3 |
| Next year | 0.13 | -0.05 – 0.36 | -0.05 | +360.0% | 126.00M | +71.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 26, 2023 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| May 15, 2023 | Jefferies | Downgrade | Buy | Hold |
| Apr 26, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 26, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Feb 6, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Feb 3, 2023 | Cantor Fitzgerald | Maintained | — | Neutral |
| Feb 1, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Jan 31, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 16, 2022 | B. Riley Securities | Downgrade | Buy | Neutral |
| Sep 23, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 20, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 12, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 21, 2022 | B. Riley Securities | Maintained | — | Buy |
| Oct 26, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Sep 17, 2020 | JMP Securities | Initiated | — | Outperform |
| Aug 3, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 28, 2020 | Cantor Fitzgerald | Maintained | — | Neutral |
| Mar 2, 2020 | B. Riley FBR | Maintained | — | Buy |
| Dec 27, 2019 | B. Riley FBR | Maintained | — | Buy |
| Dec 27, 2019 | Guggenheim | Downgrade | Buy | Neutral |
| Dec 26, 2019 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jul 11, 2019 | B. Riley | Initiated | — | Buy |
| May 13, 2019 | Guggenheim | Initiated | — | Buy |
| Feb 7, 2019 | Cantor Fitzgerald | Initiated | — | Overweight |
| Nov 12, 2018 | B. Riley FBR | Maintained | Buy | Buy |
| Aug 31, 2018 | B. Riley FBR | Maintained | Buy | Buy |
| May 5, 2018 | B. Riley FBR | Initiated | — | Buy |
| Oct 24, 2017 | Guggenheim | Initiated | — | Buy |
| Oct 9, 2017 | Jefferies | Maintained | — | Buy |